Therapeutic Asset Ratings
368 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
MNPR-101-DFO-89Zr
Pancreatic Neoplasm
Monopar Therapeutics
P1
C
(36)
Mnpr-101-Pcta-177Lu
Pancreatic Neoplasm
Monopar Therapeutics
P1
C
(36)
mrg007
Pancreatic Neoplasm
ArriVent BioPharma, Inc.
P1
C
(36)
ngm438
Pancreatic Neoplasm
NGM Biopharmaceuticals, Inc
P1
C
(36)
ngm831
Pancreatic Neoplasm
NGM Biopharmaceuticals, Inc
P1
C
(36)
np137
Pancreatic Neoplasm
Aram Hezel
P1
C
(36)
Nuv-868
Pancreatic Neoplasm
Nuvation Bio Inc.
P1
C
(36)
Obinutuzumab
Pancreatic Cancer
German Cancer Research Center
P1
C
(36)
Palbociclib
Pancreatic Neoplasm
UNC Lineberger Comprehensive Cancer Center
P1
C
(36)
Pcna Inhibitor Aoh1996
Pancreatic Neoplasm
City of Hope Medical Center
P1
C
(36)
pf-08046876
Pancreatic Neoplasm
Pfizer
P1
C
(36)
Phn-012
Pancreatic Neoplasm
Pheon Therapeutics
P1
C
(36)
PIFLUFOLASTAT
Pancreatic Neoplasm
M.D. Anderson Cancer Center
P1
C
(36)
PITAVASTATIN
Pancreatic Neoplasm
University of California, Irvine
P1
C
(36)
P-Muc1C-Allo1 Car-T Cells
Pancreatic Neoplasm
Poseida Therapeutics, Inc.
P1
C
(36)
pt0511
Pancreatic Neoplasm
PAQ Therapeutics, Inc.
P1
C
(36)
Ptm-101
Pancreatic Neoplasm
PanTher Therapeutics
P1
C
(36)
qlc1101
Pancreatic Neoplasm
Qilu Pharmaceutical Co., Ltd.
P1
C
(36)
Rimiducid
Pancreatic Neoplasm
Poseida Therapeutics, Inc.
P1
C
(36)
Rmc-4630
Pancreatic Neoplasm
The Netherlands Cancer Institute
P1
C
(36)
Rmc-5127
Pancreatic Neoplasm
Revolution Medicines, Inc.
P1
C
(36)
RSC-1255
Pancreatic Neoplasm
RasCal Therapeutics, Inc.
P1
C
(36)
Son-Dp
Pancreatic Neoplasm
Qurgen Inc.
P1
C
(36)
Sotevtamab
Pancreatic Neoplasm
ImmunityBio, Inc.
P1
C
(36)
Sysa1801 For
Pancreatic Neoplasm
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
P1
C
(36)
Showing 276 to 300 of 368 assets
Previous
Page 12 of 15
Next
